Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA getting tobacco?

This article was originally published in The Tan Sheet

Executive Summary

Sen. Tom Harkin, D-Iowa, announces Feb. 15 he co-sponsored a bipartisan bill with Sens. Edward Kennedy, D-Mass., and John Cornyn, R-Texas, to "give FDA the authority it needs to regulate the marketing and manufacture of tobacco products in an effort to curb youth smoking." Rep. Henry Waxman, D-Calif., introduced a companion bill (H.R. 1108) in the house on the same day. Sens. Mike Dewine, R-Ohio, and Edward Kennedy, D-Mass., introduced similar legislation in March 2005 (1"The Tan Sheet," March 21, 2005, In Brief)...

You may also be interested in...



Von Eschenbach cool on tobacco regulation

Despite bipartisan support in Congress for giving FDA authority to regulate marketing and manufacturing tobacco products to curb youth smoking, agency Commissioner Andrew von Eschenbach says government regulation could actually prompt smokers to accelerate their habits. In a March 8 interview with the Associated Press, von Eschenbach said reducing nicotine levels in cigarettes in an attempt to make cigarettes less likely to cause health problems could cause smokers to change their usage in order to continue inhaling their current levels of the addictive drug. Although Congress gave FDA authority over tobacco products in 1996, the Supreme Court in 2000 ruled that because the Food Drug and Cosmetic Act allows FDA to regulate products deemed unsafe for obtaining therapeutic benefit, tobacco falls outside of FDCA's regulatory scheme if it cannot be used safely for any therapeutic purpose. However, since then multiple bills have been introduced in Congress to give FDA the authority, most recently in the current session by Sens. Tom Harkin, D-Iowa, Edward Kennedy, D-Mass., and John Cornyn, R-Texas (S. 625) and by Rep. Harry Waxman, D-Calif., (H.R. 1108) (1"The Tan Sheet," Feb, 26, 2007, In Brief)...

FDA tobacco legislation

Sens. Mike DeWine (R-Ohio) and Ted Kennedy (D-Mass.) reintroduce legislation to give FDA authority to regulate tobacco products March 17. The Family Smoking Prevention and Public Health Protection Act would place the sale and marketing of tobacco products under FDA's purview and require manufacturers to list all ingredients and use more explicit warning labels, among other provisions. A similar bill passed the Senate by unanimous consent last October but did not make it to the President's desk (1"The Tan Sheet" Oct. 18, 2004, In Brief)...

Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty

The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel